FSHR IR score was not associated with clinical and pathological parameters in the TMAs cohort including patient’s age (p = 1.00), FIGO stage (p = 0.20), tumor grade (p = 0.59) or the presence of residual disease (p = 1.000) (Table S5). Here, FSHR is linked to neoplasm.